Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Meris Laboratories

This article was originally published in The Gray Sheet

Executive Summary

Expects to report 1993 revenues of $43 mil., up 20.1%, and a loss of about $8.5 mil, the firm reports April 1. The firm "has been unable to complete the financial and related portions of its annual report on Form 10-K for the year ended Dec. 31, 1993" due to "considerations associated with the ongoing private investigation being conducted by the Securities and Exchange Commission with respect to the company's 1992 financial statements." The firm simultaneously announced that it has hired Jerry Cullen to serve as chief operating officer. The position has been vacant since the May 1993 promotion of Stephen Kass to president and CEO. Cullen most recently served as senior vice president of operations at Damon Corp

Latest Headlines
See All
UsernamePublicRestriction

Register

MT002120

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel